ArticlePloS one2025
Functional vision in daily life: Clinical and patient-reported outcomes 18 months after enhanced partial range of field IOL implantation.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPartial range of field (PROF) intraocular lenses (IOLs) provide good distance visual acuity with enhanced intermediate visual acuity. Neuroadaptation to new intraocular lenses can take several months. This study investigates visual and patient-reported outcomes (PROMs) in patients implanted with the PROF IOL ICB00 (Johnson & Johnson Vision) 18 months post-surgery. A particular focus was put on spectacle independence while performing activities of daily life.
methodsThis ambispective, single-center study included 41 patients (aged 48-84). Visual acuities (distance, intermediate), refraction, and PROMs were assessed ≥18 months post-surgery. Spectacle independence was evaluated using the PRSIQ questionnaire. Patients also self-reported on visual quality, task performance, and photic phenomena.
resultsBinocular visual acuity of 0.20 logMAR or better was achieved by 100.0% of patients for uncorrected or corrected distance, by 73.2% for uncorrected intermediate, and by 79.5% for distance-corrected intermediate vision. Photic phenomena were reported by <10%. Mean visual quality scores were 1.68 ± 0.72 for distance and 2.05 ± 0.92 for intermediate vision, where 1 equaled very good and 6 equaled very poor. Complete spectacle independence was reported by 87.8% for distance and 53.7% for intermediate vision. Satisfaction rates were 90.2% (distance), 87.8% (intermediate), and 51.2% (near).
conclusionsThe ICB00 IOL provides excellent long-term distance and satisfactory intermediate vision, with high spectacle independence and even higher patient satisfaction, although most patients require spectacles for near vision.
trial registrationThis study was approved by the medical ethics committee of the Medical Chamber of North-Rhine, Germany (CE # 2124770CE01).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.